Bank Of Montreal Terns Pharmaceuticals, Inc. Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 40,971 shares of TERN stock, worth $350,302. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,971

Holding current value

$350,302

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$4.54 - $8.2 $186,008 - $335,962	40,971 New	40,971 $279,000
Q4 2022 Feb 01, 2023	BUY	$4.62 - $10.18 $896,742 - $1.98 Million	194,100 New	194,100 $1.98 Million

Others Institutions Holding TERN

# of Institutions

132

Shares Held

63.4M

Call Options Held

413K

Put Options Held

106K

Orbimed Advisors LLC San Diego, CA

7.62M
Shares

$65.1 Million
1.25% of portfolio
Vivo Capital, LLC Palo Alto, CA

6.18M
Shares

$52.9 Million
6.22% of portfolio
Deep Track Capital, LP Greenwich, CT

6.1M
Shares

$52.2 Million
1.36% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

4.95M
Shares

$42.3 Million
3.41% of portfolio
Black Rock Inc. New York, NY

4.12M
Shares

$35.2 Million
0.0% of portfolio

View Full List

About Terns Pharmaceuticals, Inc.

Ticker TERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,613,800
Market Cap $322M
Description
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...

More about TERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account